Skip to content

MIMOSA TENUIFLORA BARK POWDER

CAS 93685-96-2
62

Safety score · 0–100

Fine

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A bark powder from Mimosa hostilis — used in traditional Central and South American medicine for skin conditions, though it contains alkaloids that demand respectful formulation.

Mimosa tenuiflora (Mimosa hostilis, jurema) bark contains N,N-dimethyltryptamine (DMT) and other β-carboline alkaloids (harmine, harmaline) as well as tannins and flavonoids. While the bark is used topically in traditional medicine for wound healing and skin disorders, the presence of psychoactive and potentially sensitizing alkaloids means it requires careful handling and appropriate dilution in cosmetic formulations. Some regions have regulatory restrictions on Mimosa hostilis raw material due to its DMT content.

Skin benefits

  • Traditional wound-healing agent
  • Antimicrobial properties
  • Tannins provide astringent effect
  • Used in folk medicine for skin ulcers and burns

Known concerns

  • Contains DMT and other alkaloids — regulatory sensitivity
  • Potential for skin sensitization from alkaloid content
  • Photosensitivity risk reported in traditional use
  • May trigger allergic reactions in sensitive individuals

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Check your shelf

Find MIMOSA TENUIFLORA BARK POWDER in your products.

Scan any cosmetic product with LuxSense to see if it contains MIMOSA TENUIFLORA BARK POWDER and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.